Health tech company Commure to acquire Augmedix in $139M deal as AI scribe competition heats up
Healthcare technology company Commure plans to buy Augmedix, a healthcare artificial intelligence company founded in 2013, the companies announced Friday.Commure, which merged with Athelas last year in a $6 billion deal, is getting a foothold in the AI medical scribe market as the sector gets increasingly competitive.Augmedix shares more than doubled in early trading Friday, soaring 150%.The acquisition of the ambient AI company values it at $139 million. Augmedix shareholders will receive $2.35...
Read more at fiercehealthcare.com